Frontiers

Frontline–Quarantine?

Are Newly Treated Thyroid-Cancer Patients Hazardous to Our Health By MATTHEW D. RINGEL, MD, Professor of Medicine in the Division of Endocrinology, Diabetes and Metabolism, with joint appointment in the Division ...[Read more]
Published: Jan-06-11 | 0  Comment | 0  Link to this post

Breakthrough–The Frontiers of Cancer Research

PUT TO THE TEST Second Ohio State cancer drug enters clinical trial For the second time within 2½ years, an experimental drug created by cancer researchers at the OSUCCC – James is being tested in a clinica ...[Read more]
Published: Jan-06-11 | 0  Comment | 0  Link to this post

Of Note

GRANTS Carlo M. Croce, MD, director of Human Cancer Genetics and the John W. Wolfe Chair in Human Cancer Genetics, has received a $1.9 million, five-year NCI grant to study microRNAs and ultraconserved noncoding RNAs as biomarkers ...[Read more]
Published: Jan-06-11 | 0  Comment | 0  Link to this post

United Front

Left to right: Kay Huebner, PhD, professor of Molecular Virology, Immunology and Medical Genetics; Bhuvaneswari Ram aswamy, MD, assistant professor of Internal Medicine; Charles Shapiro, MD, director of Breast Medical Oncolog ...[Read more]
Published: Jan-06-11 | 0  Comment | 0  Link to this post

Small Science

Left to right:James Lee, PhD, professor and director of the National Science Foundation Center for Affordable Nanoengineering of Polymeric Biomedical Devices at Ohio State; Chenquang Zhou, PhD candidate, Pharmaceutics; Jo ...[Read more]
Published: Jan-06-11 | 0  Comment | 0  Link to this post

Dissecting the Bucket Brigade

Gustavo Leone, PhD, OSUCCC – James associate director of Basic Research When a family of transcription factors failed to perform as expected in animal experiments, an Ohio State cancer researcher began a series of painstakin ...[Read more]
Published: Jan-06-11 | 2  Comments | 0  Link to this post

Bench to Bedside

OSU-10079 – A Phase 1 Study of Lenalidomide Maintenance Following Allogeneic Hematopoietic Cell Transplantation in Patients with Select High-Risk Hematological Malignancies HYPOTHESIS: The use of lenalidomide post-transplant in patients with high-r ...[Read more]
Published: Jan-06-11 | 0  Comment | 0  Link to this post

Need to Know

CAPTURE THE GLOW A multispectral fluorescence imaging system is now available to OSUCCC – James investigators through the Wright Center of Innovation's Molecular Imaging Agents Laboratory. The Maestro EX, manufactured by Cambridge Researc ...[Read more]
Published: Jan-06-11 | 1  Comment | 0  Link to this post